Austria’s biotech industry has grown rapidly, with Vienna becoming a healthcare hub for over 200 companies. These biotechs focus heavily on health applications, particularly in diagnostic tools and treatments for various diseases. Notably, several companies quickly launched COVID-19 programs during the pandemic. One prime example is a:head bio, which has raised over €4 million ($4.32 million) in funding, and is utilising AI and 3D culture technology to develop treatments for neuropsychiatric disorders. Many of these younger biotechs are based at the Vienna Biocenter, home to over 40 startups.
How the explosion in machine identities is changing cyber defense
The rapid adoption of machine identities such as AI agents is creating new vulnerabilities and fresh challenges for IT teams
